(R)-Valiolamine voglibose dihydrochloride

CAS : 1303996-67-9

Ref. 3D-DCC99667

Informations sur le produit

• Nom: (R)-Valiolamine voglibose dihydrochloride

Description

(R)-Valiolamine voglibose dihydrochloride is an analog of voglibose that acts as a potent inhibitor of alpha-glucosidases. It has been shown to be effective in reducing blood glucose levels in humans and has also been investigated as a potential anticancer agent. (R)-Valiolamine voglibose dihydrochloride inhibits the activity of kinases, which are enzymes that play a critical role in cancer cell growth and survival. This inhibition leads to the induction of apoptosis and the suppression of tumor growth. Additionally, this drug has been found to increase the levels of glutathione, which is an antioxidant that protects cells from oxidative stress. (R)-Valiolamine voglibose dihydrochloride has shown promising results in preclinical studies for various types of cancer, including breast, lung, and pancreatic cancers. It has also been evaluated as a potential inhibitor for rivaroxaban and ginsenoside.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 442.5 g/mol
• Formule: C₁₇H₃₄N₂O₁₁
• Degré de pureté: Min. 95%